Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia

INTRODUCTION: Guidelines for the use of cerebrospinal fluid (CSF) biomarkers in the diagnosis of Alzheimer's disease (AD) establish that each laboratory must use internally qualified cutoff values. We determined the concentrations of biomarkers that discriminate cases from controls and combinat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (Amst)
Main Authors: Forlenza, Orestes V., Radanovic, Marcia, Talib, Leda L., Aprahamian, Ivan, Diniz, Breno S., Zetterberg, Henrik, Gattaz, Wagner F.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2015
Assuntos:
CSF Biomarkers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879480/
https://ncbi.nlm.nih.gov/pubmed/27239524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.09.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares